The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-omic characterization of gastrointestinal stromal tumor (GIST) in a large real-world patient cohort.
 
Jonathan C. Trent
Consulting or Advisory Role - AADi; Agios; Bayer; Blueprint Medicines; Boehringer Ingelheim; C4 Therapeutics; Cogent Medicine; Daiichi Sankyo; Deciphera; Epizyme; Foghorn Therapeutics; SERVIER
 
David Gómez-Peregrina
No Relationships to Disclose
 
Andrew Elliott
Employment - Caris Life Sciences
 
Sosipatros Alexandros Boikos
No Relationships to Disclose
 
Vaia Florou
Consulting or Advisory Role - Deciphera; Incyte
 
Margaret vonMehren
No Relationships to Disclose
 
John A. Charlson
Consulting or Advisory Role - Adaptimmune; Deciphera
Research Funding - Lilly (Inst)
 
Gabriel Tinoco
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan; SERVIER
 
Robert G. Maki
Employment - PEEL Therapeutics
Consulting or Advisory Role - Bayer; Deciphera; Ipsen; PEEL Therapeutics; UpToDate
Speakers' Bureau - MJH Life Sciences
Research Funding - Amgen (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); C4 Therapeutics (Inst); Daiichi (Inst); Exelixis (Inst); InhibRx (Inst); PEEL Therapeutics (Inst); Presage Biosciences (Inst); Rain Therapeutics (Inst); Regeneron (Inst); Regeneron (Inst); SARC: Sarcoma Alliance for Research though Collaboration (Inst); SpringWorks Therapeutics (Inst); SynOx (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
 
Suzanne George
Stock and Other Ownership Interests - Abbott Laboratories
Honoraria - CStone Pharmaceuticals
Consulting or Advisory Role - Bayer; BioAtla; Blueprint Medicines; Daiichi; deciphera; Immunicum; Kayothera; Lilly; MORE Health; Research to Practice; UpToDate
Research Funding - BioAtla; Blueprint Medicines (Inst); Daiichi Sankyo RD Novare (Inst); Deciphera (Inst); Eisai (Inst); IDRx (Inst); Merck (Inst); SpringWorks Therapeutics (Inst); Theseus Pharmaceuticals (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Expert Testimony - Bayer
Other Relationship - Research to Practice; WCG
 
Aditi Dhir
No Relationships to Disclose
 
Daruka Mahadevan
Honoraria - Caris Life Sciences; Guardant Health
Speakers' Bureau - Caris Life Sciences; Guardant Health
Travel, Accommodations, Expenses - Caris Life Sciences; Guardant Health
 
Matthew James Oberley
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
George W. Sledge
Leadership - Syndax; Tessa Therapeutics
Stock and Other Ownership Interests - Pionyr; Syndax; Tessa Therapeutics
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; G1 Therapeutics; GRAIL; Synaffix; Syndax; Verseau Therapeutics
Research Funding - Genentech/Roche (Inst); Pfizer (Inst); QED Therapeutics (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; Tessa Therapeutics; Verseau Therapeutics
 
Gina Z. D'Amato
Consulting or Advisory Role - Blueprint Medicines; Daiichi Sankyo/Lilly; Deciphera; Epizyme
 
Cesar Serrano
Honoraria - Deciphera; PharmaMar
Consulting or Advisory Role - Blueprint Medicines; Cogent Biosciences; Deciphera; IDRX; Immunicum
Research Funding - IDRX (Inst); Karyopharm Therapeutics (Inst)
Travel, Accommodations, Expenses - Bayer; Gilead Sciences; Pfizer; PharmaMar